Soleus Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-450,500
| Closed | -$6.92M | – | 101 |
|
|
2025
Q1 | $6.92M | Sell |
450,500
-1,642,500
| -78% | -$25.2M | 0.5% | 44 |
|
|
2024
Q4 | $46.1M | Buy |
+2,093,000
| New | +$46.1M | 2.9% | 8 |
|
|
2024
Q3 | – | Sell |
-586,499
| Closed | -$9.53M | – | 105 |
|
|
2024
Q2 | $9.53M | Sell |
586,499
-2,899,941
| -83% | -$47.1M | 0.84% | 38 |
|
|
2024
Q1 | $49.2M | Sell |
3,486,440
-2,078,000
| -37% | -$29.3M | 3.65% | 4 |
|
|
2023
Q4 | $58.1M | Sell |
5,564,440
-487,724
| -8% | -$5.09M | 6.45% | 1 |
|
|
2023
Q3 | $61.7M | Buy |
6,052,164
+1,802,164
| +42% | +$18.4M | 5.7% | 2 |
|
|
2023
Q2 | $32M | Buy |
+4,250,000
| New | +$32M | 3.56% | 7 |
|